a divergent approach, conserving exhaustible pharmaceutical knowledge so that the fruits of pharmaceutical innovation do …

highlights critical issues for the political economy of innovation and presents a review of empirical studies that show that data … adoption has no benefits because there are no positive effects on internal technological innovation, nor reduction of the …

, distribution and trade in pharmaceuticals and related supplies are subject to government regulatory control at a number of levels … differential regulation may unnecessarily hinder the cross-border movement of pharmaceuticals, particularly among regions that … related supplies should not disguise the fact that innovation is fundamentally important in making progress against disease …

these investments to occur. I propose adopting innovation prizes with awards large enough to justify investments in broad …